Anthropic Drug Manufacturers - General Profile - TipRanks - Anthropic Analyst
11 Followers
Anthropic Drug Manufacturers - General TipRanks - Anthropic
AI Analyst
Success Rate
22 out of 38 ratings made a profit
Average Return
+6.50%
Average return per rating
Time Frame
Compare to
Copying Anthropic Drug Manufacturers - General's trades since 2025 and holding each position for 1 Year would result in 57.89% of your transactions generating a profit, with an average return of 6.5% per rating.
Stock Rating Distribution
70.43% Hold
21.98% Buy
7.59% Sell
Distribution of Anthropic Drug Manufacturers - General's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Anthropic Drug Manufacturers - General
Anthropic Drug Manufacturers - General's Stock Coverage
AstraZeneca
Nov 26, 2025
Buy
Upgraded
―
3Ratings
+0.80%
Sanofi
Jan 30, 2026
Hold
Downgraded
$50.00
(12.89% Upside)
3Ratings
-5.90%
Haw Par
Mar 17, 2026
Hold
Downgraded
S$16.50
(-1.02% Downside)
7Ratings
-5.30%
Roche Holding AG
Mar 26, 2026
Hold
Reiterated
CHF318.00
(-4.93% Downside)
21Ratings
0.00%
Sanofi
Mar 26, 2026
Hold
Reiterated
€82.00
(6.66% Upside)
5Ratings
―
0.00%
Roche Holding
Apr 18, 2026
Buy
Reiterated
$55.00
(3.13% Upside)
27Ratings
+1.77%
Johnson & Johnson
Apr 28, 2026
Hold
Reiterated
$238.00
(1.56% Upside)
9Ratings
+28.00%
Astellas Pharma
Apr 28, 2026
Hold
Reiterated
¥2,374.00
(4.60% Upside)
15Ratings
+7.35%
Chugai Pharmaceutical Co
Apr 28, 2026
Buy
Reiterated
¥8,190.00
(1.24% Upside)
16Ratings
-0.10%
Novartis
Apr 30, 2026
Hold
Reiterated
$149.00
(-1.98% Downside)
16Ratings
+19.60%
List of latest recommendations made by Anthropic Drug Manufacturers - General. Click to expand and see Anthropic Drug Manufacturers - General's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Anthropic Drug Manufacturers - General activity FAQ
What is the performance of Anthropic Drug Manufacturers - General's recommendations?
The percentage of profitable recommendations made by Anthropic Drug Manufacturers - General is 58%, and the average return per transaction is 6.50%.
What stocks does Anthropic Drug Manufacturers - General cover?
What was Anthropic Drug Manufacturers - General's most profitable rating?
Anthropic Drug Manufacturers - General’s most profitable ratings was a sell on SRXH stock on Jan 04, 2026 - Today. The return on the trade was +45.50%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here